Blood markers may reveal hidden risks in obesity

NCT ID NCT07431593

Recruiting now Knowledge-focused Sponsor: University of Rijeka Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two blood inflammation markers, SII and SIRI, to see if they can help predict metabolic problems like insulin resistance and fatty liver in people who are overweight or have obesity. Researchers will follow 200 adults for up to 3 years, tracking their diet, lab results, and response to treatments. The goal is to find a simple, affordable way to identify those at higher risk and guide better care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Inflammation inflammatory disease metabolic syndrome X Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATION METABOLIC SYNDROME OVERWEIGHT AND OBESITY

Contacts and locations

Locations

General Hospital Varaždin
RECRUITING

Varaždin, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.